FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071737 [Registered on: 31/07/2024] Trial Registered Prospectively
Last Modified On: 26/07/2024
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Prospective study 
Study Design  Other 
Public Title of Study   Role of ultrasonographic Inferior Vena Cava collapsibility index in predicting spinal anaesthesia induced hypotension in elective lower abdominal surgeries.  
Scientific Title of Study   Role of ultrasonographic Inferior Vena Cava collapsibility index in predicting spinal anaesthesia induced hypotension in elective lower abdominal surgeries. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Disha Shah 
Designation  Senior Resident doctor 
Affiliation   
Address  Room no 105, ground floor, Anaesthesiology department, GCS Medical College Hospital and Research centre, Opp DRM Office, Near Chamunda Bridge, Naroda road, Ahmedabad

Ahmadabad
GUJARAT
380025
India 
Phone    
Fax    
Email  dr.disha1994@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shruti Desai 
Designation  Assistant professor  
Affiliation   
Address  Room no 105, ground floor, Anaesthesiology Department, GCS Medical College Hospital and Research centre, Opp DRM Office, Near Chamunda Bridge, Naroda road, Ahmedabad

Ahmadabad
GUJARAT
380025
India 
Phone  9429525791  
Fax    
Email  shru30791@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shruti Desai 
Designation  Assistant professor  
Affiliation   
Address  Room no 105, ground floor, Anaesthesiology Department, GCS Medical College Hospital and Research centre, Opp DRM Office, Near Chamunda Bridge, Naroda road, Ahmedabad

Ahmadabad
GUJARAT
380025
India 
Phone  9429525791  
Fax    
Email  shru30791@gmail.com  
 
Source of Monetary or Material Support  
GCS Medical College Hospital and Research centre,Anaesthesiology Department, ground floor, room no 105, Opp DRM Office, Near Chamunda Bridge, Naroda road, Ahmedabad - 380025, Gujarat, India 
 
Primary Sponsor  
Name  GCS Medical College Hospital and Research centre  
Address  GCS Medical College Hospital and Research centre,Anaesthesiology Department, ground floor, room no 105, Opp DRM Office, Near Chamunda Bridge, Naroda road, Ahmedabad - 380025, Gujarat, India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shruti Desai  GCS Medical College Hospital and Research centre   Room no 105, ground floor, Anaesthesiology Department, Opp. DRM Office, Near Chamunda Bridge, Naroda road, Ahmedabad- 380025
Ahmadabad
GUJARAT 
9429525791

shru30791@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Instituitional Ethics Committee (IEC GCSMCH & RC)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Not applicable 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients who have given written informed consent posted for elective lower abdominal surgeries under spinal anaesthesia requiring spinal level T6-T8 under supine position, ASA grade I and II and BMI less than 30 kg/m2 will be included in our study
 
 
ExclusionCriteria 
Details  ASA III and IV
Pregnant patients
Patients with baseline BP less than 90mmHg
Raised intra-abdominal pressure
BMI more than 30kg/m2
Patients undergoing unilateral spinal anaesthesia
Patients with known allergy to local anaesthetics
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Ultrasonographic inferior vena cava collapsibility index more 35 will predict spinal anaesthesia induced hypotension   8 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Non-invasive predictor for spinal anaesthesia induced hypotension   8 weeks 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   12/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary    Written informed consent will be taken. Patients will be kept nil by mouth as per standard protocol. In the operating theatre, 18G cannula will be secured in a peripheral vein, standard monitoring will be applied and baseline HR, SBP, DBP, MAP & SpO2 will be recorded before administering SA in supine position.
Ultrasound guided IVC diameter measurements will be done by an experienced anaesthetist using a curvilinear probe of 1-8 MHz during spontaneous breathing through subxiphoid view lateral to the IVC-hepatic vein junction. IVC anterioposterior diameter which is maximum during expiration (IVCmax) and minimum during inspiration (IVCmin) will be taken in one respiratory cycle using M-mode of ultrasound. IVCCI will be calculated using the formula: [{IVCmax-IVCmin}/IVCmax]*100.
No fluid preloading will be done and the infusion of Ringer’s Lactate solution at a rate of 10ml/kg/hr will be started only after administration of SA in a sitting position at L3-L4 intervertebral space with a dose of 3.5 ml of 0.5% hyperbaric bupivacaine through 25G spinal needle to achieve spinal blockade of T8.
Patients will be kept supine after SA and the pin prick test will be used to evaluate the level of sensory blockade. HR, SBP, DBP, MAP and SpO2 will be recorded every 2 minutes for 10 minutes and every 5 minutes for 30 minutes after the administration of SA.
SAIH (spinal anaesthesia induced hypotension) will be defined as a decrease in SBP by more than 20% of the baseline value or MAP <60 mmHg.
Any episode of hypotension will be noted and managed with 6mg i.v. mephentermine to keep BP within 20% of baseline. Any complications like bradycardia, nausea or vomiting will be noted and managed accordingly
All the factors known to affect SAIH i.e. age, gender, height, weight, BMI, IVCCI will be included in the final multivariate model for finding the single most useful SAIH predicting variable..

 
Close